🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/06/2004 | 71,12 | 71,53 | 69,81 | 70,07 | -1,32% | 2,42% | 257.121 |
| 07/06/2004 | 74,90 | 74,90 | 69,66 | 71,00 | -5,20% | 7,00% | 487.980 |
| 04/06/2004 | 76,21 | 76,84 | 74,04 | 74,90 | -0,89% | 3,68% | 210.073 |
| 03/06/2004 | 76,77 | 77,93 | 75,57 | 75,57 | -1,75% | 3,07% | 170.426 |
| 02/06/2004 | 77,55 | 78,86 | 75,95 | 76,92 | -0,72% | 3,76% | 142.026 |
| 01/06/2004 | 76,47 | 77,67 | 75,42 | 77,48 | +0,88% | 2,94% | 181.406 |
| 28/05/2004 | 74,67 | 77,22 | 73,55 | 76,81 | +2,19% | 4,91% | 342.428 |
| 27/05/2004 | 78,98 | 79,09 | 73,51 | 75,16 | -4,15% | 7,06% | 497.357 |
| 26/05/2004 | 71,72 | 78,98 | 71,64 | 78,42 | +9,17% | 10,23% | 710.877 |
| 25/05/2004 | 68,80 | 72,02 | 67,86 | 71,83 | +4,18% | 6,04% | 302.513 |
| 24/05/2004 | 66,63 | 69,28 | 66,63 | 68,95 | +3,66% | 3,99% | 195.326 |
| 21/05/2004 | 68,05 | 68,16 | 65,54 | 66,51 | -1,28% | 3,85% | 215.897 |
| 20/05/2004 | 67,94 | 68,76 | 66,70 | 67,37 | -0,44% | 3,03% | 322.657 |
| 19/05/2004 | 67,97 | 68,95 | 67,26 | 67,67 | +0,33% | 2,48% | 451.057 |
| 18/05/2004 | 67,19 | 68,12 | 66,44 | 67,45 | +1,41% | 2,51% | 357.202 |
| 17/05/2004 | 65,32 | 67,34 | 65,13 | 66,51 | +1,83% | 3,38% | 521.910 |
| 14/05/2004 | 63,86 | 66,33 | 63,56 | 65,32 | +2,29% | 4,34% | 428.428 |
| 13/05/2004 | 62,51 | 64,79 | 62,47 | 63,86 | +1,13% | 3,71% | 386.216 |
| 12/05/2004 | 62,43 | 63,56 | 60,26 | 63,14 | -0,53% | 5,28% | 414.643 |
| 11/05/2004 | 61,01 | 63,74 | 61,01 | 63,48 | +4,95% | 4,48% | 632.651 |
| 10/05/2004 | 61,76 | 62,10 | 59,21 | 60,49 | -2,36% | 4,67% | 606.228 |
| 07/05/2004 | 65,65 | 65,95 | 60,67 | 61,95 | -5,97% | 8,04% | 865.700 |
| 06/05/2004 | 68,12 | 70,74 | 65,28 | 65,88 | -3,83% | 8,02% | 907.138 |
| 05/05/2004 | 69,43 | 73,92 | 63,82 | 68,50 | -15,51% | 14,56% | 2.835.680 |
| 04/05/2004 | 83,21 | 84,78 | 80,29 | 81,07 | -1,23% | 5,40% | 453.889 |
| 03/05/2004 | 80,47 | 86,05 | 79,99 | 82,08 | +2,43% | 7,53% | 465.645 |
| 30/04/2004 | 84,59 | 84,93 | 78,27 | 80,14 | -5,60% | 7,88% | 448.252 |
| 29/04/2004 | 85,34 | 87,40 | 82,98 | 84,89 | -0,70% | 5,18% | 322.443 |
| 28/04/2004 | 89,91 | 90,58 | 84,07 | 85,49 | -4,91% | 7,24% | 552.287 |
| 27/04/2004 | 87,92 | 93,24 | 87,92 | 89,91 | +1,09% | 6,05% | 717.743 |